FREE Account Opening + No Clearing Fees
Loading...

MKVentures Capital Rights Issue 2023 vs Piramal Pharma Rights Issue 2023

Comparision between MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023. MKVentures Capital Rights Issue 2023 is listed on BSE while Piramal Pharma Rights Issue 2023 is listed on BSE, NSE.

  MKVentures Capital Limited Piramal Pharma Limited
Logo MKVentures Capital Rights Issue 2023 Logo Piramal Pharma Rights Issue 2023 Logo
Listing At BSE BSE, NSE
Terms of Payment

On Application, investors will have to pay Rs. 936 per Rights Equity Share which constitutes 100% of the Issue Price.

The full amount of Rs. 81 for rights equity shares has to be paid on application.

Entitlement 1 Rights Equity Share(s) for every 8 fully paid-up Equity Shares held on Record Date 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date
Application Form Application Form Application Form
Letter of Offer Letter of Offer Letter of Offer
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Lead Managers Choice Capital Advisors Pvt Ltd ICICI Securities Limited

Rights Issue Size and Price

The issue size of MKVentures Capital Rights Issue 2023 rights issue is ₹39.97 Crores, whereas Piramal Pharma Rights Issue 2023 rights issue size is ₹1,050.00 Crores.

  MKVentures Capital Limited Piramal Pharma Limited
Issue Size 4,27,050 shares 12,96,29,630 shares
Issue Size (Amount) ₹39.97 Crores ₹1,050.00 Crores
Issue Price ₹936 per share ₹81 per share
Face Value ₹10 per share ₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of MKVentures Capital Rights Issue 2023 is Apr 04, 2023 while record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023.

  MKVentures Capital Limited Piramal Pharma Limited
Record Date Apr 04, 2023 Aug 02, 2023
Credit of Rights Entitlements Apr 13, 2023
Bid/Offer Opens On Apr 17, 2023 Aug 08, 2023
Renunciation of Rights Entitlements Apr 20, 2023 Aug 10, 2023
Bid/Offer Closes On Apr 25, 2023 Aug 17, 2023
Deemed Date of Allotment May 03, 2023 Aug 23, 2023
Credit Date May 04, 2023 Aug 24, 2023
Listing Date May 08, 2023 Aug 28, 2023

Financials details

Comparison of MKVentures Capital Rights Issue 2023 and Piramal Pharma Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

  MKVentures Capital Limited Piramal Pharma Limited
Financial
MKVentures Capital Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and Surplus
31-Mar-208.671.58-1.470.02
31-Mar-2111.868.312.700.02
31-Mar-2215.5013.724.570.02
Amount in ₹ Crore
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore

Comments

Add a public comment...